认识到撒哈拉以南非洲地区常规病毒载量检测的潜力。 - Suppr

Suppr

超能文献

Realizing the potential of routine viral load testing in sub-Saharan Africa.

作者信息

El-Sadr Wafaa M, Rabkin Miriam, Nkengasong John, Birx Deborah L

机构信息

ICAP at Columbia University, New York, NY, USA.

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

出版信息

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25010.

DOI:10.1002/jia2.25010

PMID:29130621

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5978658/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/322b/5978658/305c803db18c/JIA2-20-e25010-g001.jpg

相似文献

Realizing the potential of routine viral load testing in sub-Saharan Africa.认识到撒哈拉以南非洲地区常规病毒载量检测的潜力。

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25010.

Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.撒哈拉以南非洲成人治疗队列中一线抗逆转录病毒治疗的监测和转换：协作分析。

Lancet HIV. 2015 Jul;2(7):e271-8. doi: 10.1016/S2352-3018(15)00087-9. Epub 2015 Jun 16.

Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.扩大艾滋病毒病毒载量监测范围的进展情况-撒哈拉以南非洲七个国家，2015 年 1 月至 2016 年 6 月。

MMWR Morb Mortal Wkly Rep. 2016 Dec 2;65(47):1332-1335. doi: 10.15585/mmwr.mm6547a2.

The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates.评估撒哈拉以南非洲地区艾滋病毒耐药性检测的REVAMP试验：资源有限环境下临床试验设计的案例研究，以优化有效性和成本效益估计。

HIV Clin Trials. 2017 Jul;18(4):149-155. doi: 10.1080/15284336.2017.1349028. Epub 2017 Jul 18.

Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.简化撒哈拉以南非洲的二线抗逆转录病毒治疗转换：使用单一病毒载量定义依非韦伦为基础的一线治疗失败的预测效果。

AIDS. 2019 Aug 1;33(10):1635-1644. doi: 10.1097/QAD.0000000000002234.

[HIV in Sub-Saharan Africa: Where Are We Today?].[撒哈拉以南非洲的艾滋病病毒：我们如今处于何种状况？]

Praxis (Bern 1994). 2019 Nov;108(15):971-976. doi: 10.1024/1661-8157/a003334.

Factors Associated With Success in Reducing HIV Mother-to-child Transmission in Sub-Saharan Africa: Interviews With Key Stakeholders.与撒哈拉以南非洲地区降低艾滋病毒母婴传播成功率相关的因素：与主要利益攸关方的访谈。

Clin Ther. 2019 Oct;41(10):2102-2110.e1. doi: 10.1016/j.clinthera.2019.08.012. Epub 2019 Sep 12.

Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.出生于非洲并居住在法国的HIV-1感染患者的特征及对抗逆转录病毒疗法的反应

HIV Med. 2007 Apr;8(3):164-70. doi: 10.1111/j.1468-1293.2007.00447.x.

Community-driven demand creation for the use of routine viral load testing: a model to scale up routine viral load testing.社区推动的常规病毒载量检测使用需求创造：扩大常规病毒载量检测规模的模型

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25009.

Predictors of HIV Testing among Youth in Sub-Saharan Africa: A Cross-Sectional Study.撒哈拉以南非洲地区青少年艾滋病毒检测的预测因素：一项横断面研究。

PLoS One. 2016 Oct 5;11(10):e0164052. doi: 10.1371/journal.pone.0164052. eCollection 2016.

引用本文的文献

Factors affecting viral suppression or rebound in people living with HIV and receiving antiretroviral therapy in Ghana.影响加纳接受抗逆转录病毒治疗的艾滋病毒感染者病毒抑制或反弹的因素。

Front Public Health. 2025 Mar 19;13:1508793. doi: 10.3389/fpubh.2025.1508793. eCollection 2025.

The potential promise and pitfalls of point-of-care viral load monitoring to expedite HIV treatment decision-making in rural Uganda: a qualitative study.在乌干达农村，即时病毒载量监测加速艾滋病治疗决策的潜在前景和陷阱：一项定性研究。

BMC Health Serv Res. 2024 Oct 22;24(1):1265. doi: 10.1186/s12913-024-11747-w.

Performance of patient-collected dried blood specimens for HIV-1 viral load testing in South Africa.南非患者采集的干血标本用于HIV-1病毒载量检测的性能

AIDS. 2024 Dec 1;38(15):2050-2055. doi: 10.1097/QAD.0000000000004011. Epub 2024 Sep 12.

Assessment of the effect of pre-conception care on preventing mother-to-child transmission of HIV in Nyeri County.评估孕前护理对预防奈罗伊县母婴传播 HIV 的效果。

Pan Afr Med J. 2024 Mar 27;47:144. doi: 10.11604/pamj.2024.47.144.37196. eCollection 2024.

Virological Suppression and its Predictors Among HIV/AIDS Patients on Antiretroviral Therapy in Ethiopia: Systematic Review and Meta-analysis.埃塞俄比亚接受抗逆转录病毒治疗的艾滋病毒/艾滋病患者的病毒学抑制及其预测因素：系统评价和荟萃分析

Open Forum Infect Dis. 2024 Mar 21;11(4):ofae168. doi: 10.1093/ofid/ofae168. eCollection 2024 Apr.

"They test my blood to know how much blood is in my body": the untapped potential of promoting viral load literacy to support adherence and viral suppression among adolescents living with HIV.“他们检测我的血液，以了解我体内的血液量”：提高病毒载量知识水平以支持艾滋病毒感染者青少年坚持治疗和病毒抑制的未开发潜力。

J Int AIDS Soc. 2023 Oct;26(10):e26153. doi: 10.1002/jia2.26153.

Clinic-based SAMBA-II vs centralized laboratory viral load assays among HIV-1 infected children, adolescents and young adults in rural Zimbabwe: A randomized controlled trial.以诊所为基础的 SAMBA-II 与集中式实验室病毒载量检测在津巴布韦农村地区 HIV-1 感染的儿童、青少年和年轻成年人中的比较：一项随机对照试验。

PLoS One. 2023 Feb 14;18(2):e0281279. doi: 10.1371/journal.pone.0281279. eCollection 2023.

Incidence, survival time and associated factors of virological failure among adult HIV/AIDS patients on first line antiretroviral therapy in St. Paul's Hospital Millennium Medical College-A retrospective cohort study.圣保罗医院千年医科大学成人 HIV/AIDS 患者一线抗逆转录病毒治疗中病毒学失败的发生率、生存时间和相关因素：一项回顾性队列研究。

PLoS One. 2022 Oct 13;17(10):e0275204. doi: 10.1371/journal.pone.0275204. eCollection 2022.

Virological failure and treatment switch after ART initiation among people living with HIV with and without routine viral load monitoring in Asia.亚洲地区有和无常规病毒载量监测的 HIV 感染者在开始 ART 后病毒学失败和治疗转换。

J Int AIDS Soc. 2022 Aug;25(8):e25989. doi: 10.1002/jia2.25989.

Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.津巴布韦在扩大病毒载量检测规模期间，通过强化依从性咨询后进行常规和重复病毒载量检测的病毒学结局和非抑制风险因素：使用 2014 年至 2018 年实验室数据进行的分析性横断面研究。

AIDS Res Ther. 2022 Jul 9;19(1):34. doi: 10.1186/s12981-022-00458-z.

本文引用的文献

Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016.2015年至2016年，在撒哈拉以南非洲三个国家开展的全国性基于人群的艾滋病毒影响评估（PHIA）家庭调查中，将艾滋病毒-1病毒载量结果反馈给参与者选择的医疗机构。

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25004.

Selecting a viral load threshold for routine monitoring in resource-limited settings: optimizing individual health and population impact.在资源有限的环境中选择用于常规监测的病毒载量阈值：优化个体健康和人群影响。

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25007.

Routine viral load monitoring in HIV-infected infants and children in low- and middle-income countries: challenges and opportunities.低收入和中等收入国家中感染艾滋病毒的婴幼儿的常规病毒载量监测：挑战与机遇

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25001.

The case for viral load testing in adolescents in resource-limited settings.资源有限环境下青少年病毒载量检测的理由。

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25002.

Optimal timing of viral load monitoring during pregnancy to predict viraemia at delivery in HIV-infected women initiating ART in South Africa: a simulation study.南非开始接受抗逆转录病毒治疗的感染艾滋病毒孕妇病毒载量监测的最佳时机，以预测分娩时的病毒血症：一项模拟研究。

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25000.

HIV viral load monitoring among key populations in low- and middle-income countries: challenges and opportunities.低收入和中等收入国家重点人群中的艾滋病毒病毒载量监测：挑战与机遇

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25003.

Cost-effectiveness of routine viral load monitoring in low- and middle-income countries: a systematic review.低收入和中等收入国家常规病毒载量监测的成本效益：一项系统评价

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25006.

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25009.

Scaling up HIV viral load - lessons from the large-scale implementation of HIV early infant diagnosis and CD4 testing.扩大艾滋病毒病毒载量检测——来自大规模实施艾滋病毒早期婴儿诊断和CD4检测的经验教训。

J Int AIDS Soc. 2017 Nov;20 Suppl 7(Suppl 7). doi: 10.1002/jia2.25008.

Candidates for inclusion in a universal antiretroviral regimen: dolutegravir.纳入通用抗逆转录病毒治疗方案的候选药物：多替拉韦。

Curr Opin HIV AIDS. 2017 Jul;12(4):318-323. doi: 10.1097/COH.0000000000000388.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验